| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/26/2002 | EP1215963A2 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 06/26/2002 | EP1049689B1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 06/26/2002 | EP1003517B1 Pharmaceutical composition for the treatment of so-called restless legs |
| 06/26/2002 | EP1003510A4 Method for treating headache pain with topical local anesthetic compositions |
| 06/26/2002 | EP0998288B1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 06/26/2002 | EP0956011B1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia |
| 06/26/2002 | EP0931067B1 D4 receptor selectivity piperazine derivatives |
| 06/26/2002 | EP0888114B1 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 06/26/2002 | CN1355881A Growth differentiation factor inhibitors and uses therefor |
| 06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/26/2002 | CN1355810A Prodrugs of thrombin inhibitors |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355790A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 06/26/2002 | CN1355784A Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355706A 因子 Factor |
| 06/26/2002 | CN1355696A Method to aid smoking cessation |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355049A Analgesic and its preparing process |
| 06/26/2002 | CN1355021A Percutaneous medicine of strychnine (toxiferine or securinine) and salt thereof |
| 06/26/2002 | CN1086705C Stereoselective process and intermediates for producing dihydro-2,3-benzodiazepine derivatives |
| 06/26/2002 | CN1086703C Crystalline hydrochloride of (R)-(-)-2{N-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl} benzodihydropyran |
| 06/26/2002 | CN1086702C 4-hydroxy-piperidine-derivatives |
| 06/26/2002 | CN1086698C Oxadizoles, processes for their preparation and their use as medicaments |
| 06/26/2002 | CN1086583C Powder and pellet for strengening yang |
| 06/26/2002 | CN1086578C Sulfonamides and their use |
| 06/25/2002 | US6410802 Etherification in presence of base |
| 06/25/2002 | US6410790 Analgesics |
| 06/25/2002 | US6410787 Process to prepare 2-aminoindan derivatives |
| 06/25/2002 | US6410747 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 06/25/2002 | US6410740 Heterocyclylmethyl-substituted pyrazol derivatives |
| 06/25/2002 | US6410739 Indole derivatives as 5-HT1 agonists |
| 06/25/2002 | US6410685 Reducing stress in mammals; obtain mammal, administer tripeptide, monitor mammal for reduction in products of stress response |
| 06/25/2002 | US6410592 Aminomethylcarboxylic acid derivatives |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410588 Use of cannabinoids as anti-inflammatory agents |
| 06/25/2002 | US6410582 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 06/25/2002 | US6410580 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 06/25/2002 | US6410579 Use of pramipexole for the treatment of addictive disorders |
| 06/25/2002 | US6410555 Antiepileptic agents; headaches |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410550 Aryl fused azapolycyclic compounds |
| 06/25/2002 | US6410544 Vision defects; administering pilocarpine |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
| 06/25/2002 | US6410522 Anti-depressant, stress suppressor and mood improver |
| 06/25/2002 | US6410520 Heating in aqueous solution |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | CA2240964C Piperidone tachykinin antagonists |
| 06/25/2002 | CA2234847C Formulation for respiratory tract administration |
| 06/25/2002 | CA2136893C Substituted n-piperidino-pyrazole-3-carboxamide |
| 06/25/2002 | CA2071981C The use of gaba-b selective agonists as anti-tussive agents |
| 06/20/2002 | WO2002048898A1 Method for screening for inhibitors of alzheimer's disease |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048179A1 Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3 |
| 06/20/2002 | WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 06/20/2002 | WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 06/20/2002 | WO2002048148A2 Pyrazolopyridine derivatives |
| 06/20/2002 | WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 06/20/2002 | WO2002048134A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048117A1 Quinazolinone derivatives |
| 06/20/2002 | WO2002048114A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | WO2002048105A2 Aryloxy piperidinyl derivatives for the treatment of depression |
| 06/20/2002 | WO2002048102A2 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses |
| 06/20/2002 | WO2002048096A1 Hydrazone derivatives and use thereof in medicines |
| 06/20/2002 | WO2002048092A2 Compounds for altering mitochondrial function and cellular responses |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| 06/20/2002 | WO2002047719A2 Survical promoting ncam binding and ncam ligand biding compounds |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047707A2 Selective cox-2 inhibition from non-edible plant extracts |
| 06/20/2002 | WO2002047706A2 Selective cox-2 inhibition from plant extracts |
| 06/20/2002 | WO2002047702A1 Compositions for inducing secretion of insulin-like growth factor-1 |
| 06/20/2002 | WO2002047701A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/20/2002 | WO2002047688A2 Method and apparatus for treating breakthrough pain |
| 06/20/2002 | WO2002047687A1 Urotensin-ii receptor antagonists |
| 06/20/2002 | WO2002047686A1 Substituted-4-quinolones |
| 06/20/2002 | WO2002047685A2 Nmda receptor agonist pharmaceutical compositions |
| 06/20/2002 | WO2002047671A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 06/20/2002 | WO2002047669A1 Use of ep4 receptor agonists for treating neuropathic pain |
| 06/20/2002 | WO2002047666A1 Use of a dopamine agonist with a short half-life for treating illnesses which can be treated by dopaminergic means |
| 06/20/2002 | WO2002047663A1 Self emulsifying lipid matrix (selm) |
| 06/20/2002 | WO2002047493A2 Health promoting compositions |
| 06/20/2002 | WO2002047456A2 Urotensin-ii receptor antagonists |
| 06/20/2002 | WO2002040019A8 Benzimidazole derivatives |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002028905A3 Human anti-cd40 antibodies |
| 06/20/2002 | WO2002020495A3 Inhibitors of glycogen synthase kinase 3 |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2002013766A3 Valproic acid derivatives for the treatment of pain |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | WO2002004455A3 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 06/20/2002 | WO2002003911A8 Prevention and treatment of alzheimer's disease |
| 06/20/2002 | WO2002002085A3 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |